Skip to content
Luna Metabolic
Menu

Head-to-head for women

REMEVi vs Gimme Care

REMEVi and Gimme Care both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.

REMEVi

Ranked #17 for women · Grade B

Best for: Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing.

Visit REMEVi
vs

Gimme Care

Higher score

Ranked #9 for women · Grade B

Best for: Women who want low, transparent pricing on both molecules from a LegitScript-accredited, all-50-states provider.

Visit Gimme Care

The verdict for women

Higher Luna Fit Score: Gimme Care

Gimme Care edges out REMEVi on the Luna Fit Score, 86 to 85 (B vs B). Women who want low, transparent pricing on both molecules from a LegitScript-accredited, all-50-states provider.

REMEVi is still a genuine option — an accredited nationwide program with both molecules — solid oversight, though pricing sits toward the higher end. Weigh the six women's-health factors below against your own priorities.

Side-by-side on the six factors

Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.

REMEVi Gimme Care
PCOS & hormonal suitability8383
REMEVi
Gimme
Clinical oversight & labs8585
REMEVi
Gimme
Price transparency8289
REMEVi
Gimme
Nationwide access9595
REMEVi
Gimme
Ongoing support8383
REMEVi
Gimme
Cancellation fairness8283
REMEVi
Gimme

Price, access & features

DetailREMEViGimme Care
Luna Fit Score85/100 · B86/100 · B
Overall rank#17#9
Semaglutide$199/mo$130/mo
Tirzepatide$269/mo$163/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only

REMEVi

Ranked #17 · Grade B

What we like

  • LegitScript-accredited and available in all 50 states
  • Both molecules disclosed, tirzepatide for insulin-resistant PCOS
  • Clear, predictable pricing

The caveats

  • Higher-end pricing — $199 semaglutide, $269 tirzepatide
  • No oral or brand-name option; general program without hormone specialization

Gimme Care

Ranked #9 · Grade B

What we like

  • Low, disclosed pricing on both molecules — $130 semaglutide, $163 tirzepatide
  • LegitScript-accredited and available nationwide
  • Tirzepatide included for insulin-resistant PCOS

The caveats

  • No oral option and no brand-name access
  • General program without PCOS/hormone specialization

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Luna Fit Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

More head-to-heads

Keep comparing REMEVi and Gimme Care against other providers we review for women.

Or browse the full comparison hub.